This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Bergenbio as. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Lene Raunkjaer Petersen: Innovator in Pharmaceutical Purification Processes
Introduction
Lene Raunkjaer Petersen is a notable inventor based in Farum, Denmark. She has made significant contributions to the field of pharmaceutical sciences, particularly in the purification of complex compounds. Her innovative work has led to the development of a patented process that enhances the efficiency of drug purification.
Latest Patents
Lene Raunkjaer Petersen holds a patent for a process aimed at purifying the Axl tyrosine receptor kinase inhibitor 'R428'. The patent describes a method for purifying the compound 1-(6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazine-3-yl)-N-(7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulene-2-yl)-1H-1,2,4-triazole-3,5-diamine free base. The process involves dissolving a quantity of crude compound in a mixed solvent of Calcohol and water, along with an acid, and subsequently increasing the pH to precipitate the desired free base from the solution.
Career Highlights
Throughout her career, Lene has worked with various companies, including Bergenbio AS and Bergenbio ASA. Her experience in these organizations has allowed her to refine her skills in pharmaceutical research and development, contributing to advancements in drug formulation and purification techniques.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Lene Raunkjaer Petersen's innovative work in the purification of pharmaceutical compounds exemplifies her dedication to advancing drug development processes. Her contributions are significant in the field of pharmaceutical sciences, showcasing the impact of her inventions on healthcare.